Vivos Therapeutics, Inc.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Littleton, CO
VVOS chart
What traders are saying about $VVOS
Latest postsVivos Therapeutics, Inc. news
- Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates
Yahoo Finance ·
- Vivos Therapeutics (VVOS) Stock Forecast & Analyst Ratings
Moomoo ·
- ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Lags Revenue Estimates
Yahoo Finance ·
- CORRECTION: SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test
Yahoo Finance ·
- Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard
Yahoo Finance ·
- SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test
Yahoo Finance ·
- BC-Most Active Stocks
Yahoo Finance ·
- Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel
Yahoo Finance ·
- Vivos to buy 50% stake in SOD Sciences’ pseudohypoxia test
medicaldevice-network.com ·
- Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test
Yahoo Finance ·
- Vivos Therapeutics Targets $3.6 Million in Annual Cost Reductions as Revenue Growth Initiatives Accelerate
investorshub.advfn.com ·
- Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
Yahoo Finance ·
Vivos Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $17.4M | $15.0M | $13.8M | $16.0M |
| Net income | -$21.2M | -$11.1M | -$13.6M | -$23.8M |
| Diluted EPS | $-2.07 | $-2.22 | $-11.14 | $-25.90 |
| Total assets (year end) | $25.2M | $15.3M | $10.7M | $13.7M |
| Cash and equivalents (year end) | $2.0M | $6.3M | $1.6M | $3.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Vivos Therapeutics, Inc.
- Ticker
- VVOS (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Littleton, CO
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1716166
- Former names
- Vivos BioTechnologies, Inc.
Frequently asked questions
What exchange is Vivos Therapeutics, Inc. listed on?
Vivos Therapeutics, Inc. trades on the Nasdaq under the ticker symbol VVOS.
What industry is Vivos Therapeutics, Inc. in?
Vivos Therapeutics, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Vivos Therapeutics, Inc. headquartered?
Vivos Therapeutics, Inc.'s business address on file with the SEC is in Littleton, CO.
When does Vivos Therapeutics, Inc.'s fiscal year end?
Vivos Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Vivos Therapeutics, Inc. report?
Vivos Therapeutics, Inc. reported $17.4M in revenue for calendar year 2025, according to its SEC filings.